Published in Am J Pathol on March 01, 2003
Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. J Neurochem (2005) 1.91
Oxidative stress, cell cycle, and neurodegeneration. J Clin Invest (2003) 1.84
The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease. Proc Natl Acad Sci U S A (2007) 1.78
Redox control of the cell cycle in health and disease. Antioxid Redox Signal (2009) 1.72
Cell division in the CNS: protective response or lethal event in post-mitotic neurons? Biochim Biophys Acta (2006) 1.41
Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease. PLoS One (2010) 1.41
Age-Dependent TDP-43-Mediated Motor Neuron Degeneration Requires GSK3, hat-trick, and xmas-2. Curr Biol (2015) 1.40
Cell cycle molecules define a pathway required for neuron death in development and disease. Biochim Biophys Acta (2006) 1.35
Molecular correlates of axonal and synaptic pathology in mouse models of Batten disease. Hum Mol Genet (2009) 1.26
Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease. Neurochem Int (2008) 1.18
The neuronal expression of MYC causes a neurodegenerative phenotype in a novel transgenic mouse. Am J Pathol (2009) 1.08
Podocyte mitosis - a catastrophe. Curr Mol Med (2013) 1.05
Proteostasis and movement disorders: Parkinson's disease and amyotrophic lateral sclerosis. Cold Spring Harb Perspect Biol (2011) 1.02
Modified cell cycle status in a mouse model of altered neuronal vulnerability (slow Wallerian degeneration; Wlds). Genome Biol (2008) 1.02
Cell cycle activation and spinal cord injury. Neurotherapeutics (2011) 0.97
Functions of FUS/TLS from DNA repair to stress response: implications for ALS. ASN Neuro (2014) 0.95
Exome sequencing of case-unaffected-parents trios reveals recessive and de novo genetic variants in sporadic ALS. Sci Rep (2015) 0.91
The p53 homologue p73 accumulates in the nucleus and localizes to neurites and neurofibrillary tangles in Alzheimer disease brain. Neuropathol Appl Neurobiol (2004) 0.90
Genomic integrity and the ageing brain. Nat Rev Neurosci (2015) 0.88
Adenylyl cyclase type 3, a marker of primary cilia, is reduced in primary cell culture and in lumbar spinal cord in situ in G93A SOD1 mice. BMC Neurosci (2011) 0.88
Site-specific hyperphosphorylation of pRb in HIV-induced neurotoxicity. Mol Cell Neurosci (2011) 0.87
Notch signaling in response to excitotoxicity induces neurodegeneration via erroneous cell cycle reentry. Cell Death Differ (2015) 0.85
E2F1 localizes predominantly to neuronal cytoplasm and fails to induce expression of its transcriptional targets in human immunodeficiency virus-induced neuronal damage. Neurosci Lett (2010) 0.85
Chemotactic and mitogenic stimuli of neuronal apoptosis in patients with medically intractable temporal lobe epilepsy. Pathophysiology (2012) 0.83
Cyclin D1 in excitatory neurons of the adult brain enhances kainate-induced neurotoxicity. Neurobiol Dis (2008) 0.82
Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of aberrant cell cycle diseases: an update. ScientificWorldJournal (2012) 0.81
p53 and Cell Cycle Proteins Participate in Spinal Motor Neuron Cell Death in ALS. Open Pathol J (2010) 0.80
Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of central nervous system diseases. Neurobiol Dis (2009) 0.80
Retinoid signaling alterations in amyotrophic lateral sclerosis. Am J Neurodegener Dis (2012) 0.80
Calpain-mediated degradation of MDMx/MDM4 contributes to HIV-induced neuronal damage. Mol Cell Neurosci (2013) 0.78
Insights into the regulation of neuronal viability by nucleophosmin/B23. Exp Biol Med (Maywood) (2015) 0.78
Gene expression profiling for human iPS-derived motor neurons from sporadic ALS patients reveals a strong association between mitochondrial functions and neurodegeneration. Front Cell Neurosci (2015) 0.78
E2F1 in neurons is cleaved by calpain in an NMDA receptor-dependent manner in a model of HIV-induced neurotoxicity. J Neurochem (2014) 0.78
Transcriptional control of stem cell fate by E2Fs and pocket proteins. Front Genet (2015) 0.77
ATM and the epigenetics of the neuronal genome. Mech Ageing Dev (2013) 0.75
Distinct regulation of cell cycle and survival in lymphocytes from patients with Alzheimer's disease and amyotrophic lateral sclerosis. Int J Clin Exp Pathol (2008) 0.75
Chronic oxidative damage together with genome repair deficiency in the neurons is a double whammy for neurodegeneration: Is damage response signaling a potential therapeutic target? Mech Ageing Dev (2016) 0.75
Early induction of c-Myc is associated with neuronal cell death. Neurosci Lett (2011) 0.75
Dysregulated expression of death, stress and mitochondrion related genes in the sciatic nerve of presymptomatic SOD1(G93A) mouse model of Amyotrophic Lateral Sclerosis. Front Cell Neurosci (2015) 0.75
Genome-wide screening of indicator genes for assessing the potential carcinogenic risk of Nanjing city drinking water. Ecotoxicology (2011) 0.75
The retinoblastoma protein and cell cycle control. Cell (1995) 20.21
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell (1995) 14.90
The regulation of E2F by pRB-family proteins. Genes Dev (1998) 12.77
Effects of an Rb mutation in the mouse. Nature (1992) 11.06
The E2F transcription factor is a cellular target for the RB protein. Cell (1991) 9.62
Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature (1992) 8.16
From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci (2001) 6.48
Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc Natl Acad Sci U S A (1994) 5.11
p14ARF links the tumour suppressors RB and p53. Nature (1998) 4.78
The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet (2001) 4.54
Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature (2000) 3.83
A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet (2001) 3.59
Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science (2000) 3.12
Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol Cell (1998) 3.05
Role of the p53-homologue p73 in E2F1-induced apoptosis. Nat Genet (2000) 3.03
Apaf-1 is a transcriptional target for E2F and p53. Nat Cell Biol (2001) 2.96
Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J (1996) 2.63
DNA replication precedes neuronal cell death in Alzheimer's disease. J Neurosci (2001) 2.60
Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J Neurosci (1998) 2.48
E2F activity is regulated by cell cycle-dependent changes in subcellular localization. Mol Cell Biol (1997) 2.33
Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J Neurosci (1997) 2.00
Role of cell cycle regulatory proteins in cerebellar granule neuron apoptosis. J Neurosci (1999) 1.75
Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A (2000) 1.72
Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. Am J Pathol (1997) 1.71
Induction of DNA synthesis and apoptosis are separable functions of E2F-1. Genes Dev (1997) 1.59
Association of the p75 neurotrophin receptor with TRAF6. J Biol Chem (1999) 1.56
Cyclin dependent kinase inhibitors and dominant negative cyclin dependent kinase 4 and 6 promote survival of NGF-deprived sympathetic neurons. J Neurosci (1997) 1.54
Cyclin-dependent kinases participate in death of neurons evoked by DNA-damaging agents. J Cell Biol (1998) 1.54
A mutant neurofilament subunit causes massive, selective motor neuron death: implications for the pathogenesis of human motor neuron disease. Neuron (1994) 1.46
Inhibitors of cyclin-dependent kinases promote survival of post-mitotic neuronally differentiated PC12 cells and sympathetic neurons. J Biol Chem (1996) 1.37
E2F1 mediates death of B-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3. J Biol Chem (2000) 1.35
TRAF family proteins interact with the common neurotrophin receptor and modulate apoptosis induction. J Biol Chem (1999) 1.35
E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways. Mol Cell (1999) 1.34
Involvement of retinoblastoma family members and E2F/DP complexes in the death of neurons evoked by DNA damage. J Neurosci (2000) 1.33
G1/S cell cycle blockers and inhibitors of cyclin-dependent kinases suppress camptothecin-induced neuronal apoptosis. J Neurosci (1997) 1.31
Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F x DP, in B-amyloid-induced neuronal death. J Biol Chem (1999) 1.30
Activation of cell-cycle-associated proteins in neuronal death: a mandatory or dispensable path? Trends Neurosci (2001) 1.29
A frequent ala 4 to val superoxide dismutase-1 mutation is associated with a rapidly progressive familial amyotrophic lateral sclerosis. Hum Mol Genet (1994) 1.27
Induction and modulation of cerebellar granule neuron death by E2F-1. J Biol Chem (2000) 1.22
Multiple pathways of neuronal death induced by DNA-damaging agents, NGF deprivation, and oxidative stress. J Neurosci (1998) 1.21
The motor cortex and amyotrophic lateral sclerosis. Muscle Nerve (2001) 1.20
Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism. J Neuropathol Exp Neurol (1999) 1.17
Cell death and the cell cycle: a relationship between transformation and neurodegeneration? Trends Biochem Sci (1993) 1.14
Cell division and the nervous system: regulating the cycle from neural differentiation to death. Trends Neurosci (1996) 1.12
Regulation of E2F: a family of transcription factors involved in proliferation control. Gene (1999) 1.11
DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions. Exp Neurol (1995) 1.10
Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis. J Neurol (2000) 1.10
Increased cyclin D1 in vulnerable neurons in the hippocampus after ischaemia and epilepsy: a modulator of in vivo programmed cell death? Eur J Neurosci (1999) 1.08
ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis. Exp Neurol (1999) 1.07
Induction of cell-cycle regulators in simian immunodeficiency virus encephalitis. Am J Pathol (2000) 1.05
p53 is abnormally elevated and active in the CNS of patients with amyotrophic lateral sclerosis. Neurobiol Dis (2000) 1.04
Altered distribution of cell cycle transcriptional regulators during Alzheimer disease. J Neuropathol Exp Neurol (2002) 1.02
Apoptosis in amyotrophic lateral sclerosis: a review of the evidence. Neuropathol Appl Neurobiol (2001) 1.01
Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons. Ann Neurol (1996) 1.01
Activated microglia (BV-2) facilitation of TNF-alpha-mediated motor neuron death in vitro. J Neuroimmunol (2002) 1.00
Genetic mapping of a mouse modifier gene that can prevent ALS onset. Genomics (2000) 1.00
Delaying caspase activation by Bcl-2: A clue to disease retardation in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurosci (2000) 0.98
Altered subcellular distribution of transcriptional regulators in response to Abeta peptide and during Alzheimer's disease. Mech Ageing Dev (2001) 0.97
New pathological findings in amyotrophic lateral sclerosis. J Neurol Sci (1994) 0.96
Hyperphosphorylation of the retinoblastoma gene product and altered subcellular distribution of E2F-1 during Alzheimer's disease and amyotrophic lateral sclerosis. J Alzheimers Dis (2001) 0.96
In vitro induction of neuronal apoptosis by anti-Fas antibody-containing sera from amyotrophic lateral sclerosis patients. J Neuroimmunol (2000) 0.95
Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease. Lab Invest (1997) 0.92
Motor neuron degeneration is attenuated in bax-deficient neurons in vitro. J Neurosci Res (1999) 0.91
DNA binding activity of the fetal Alz-50 clone 1 (FAC1) protein is enhanced by phosphorylation. Biochem Biophys Res Commun (1999) 0.89
Regulation of the retinoblastoma-dependent Mdm2 and E2F-1 signaling pathways during neuronal apoptosis. Mol Cell Neurosci (2001) 0.88
Terminal dUTP nick end labeling (TUNEL) positive cells in the different regions of the brain in normal aging and Alzheimer patients. J Mol Neurosci (1997) 0.87
Activity of the human cytochrome c1 promoter is modulated by E2F. Biochem J (2000) 0.86
Ubiquitin and neurofilament expression in anterior horn cells in amyotrophic lateral sclerosis: possible clues to the pathogenesis. Neuropathol Appl Neurobiol (1994) 0.82
Interleukin-1beta converting enzyme/Caspase-1 (ICE/Caspase-1) and soluble APO-1/Fas/CD 95 receptor in amyotrophic lateral sclerosis patients. Acta Neurol Scand (2001) 0.80
A novel apoptotic cascade mediated by CDK4 in rat pheochromocytoma PC12 cells. Biochem Biophys Res Commun (1999) 0.76
Whole-genome analysis of sporadic amyotrophic lateral sclerosis. N Engl J Med (2007) 3.33
Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue. PLoS One (2010) 2.49
Common molecular signature in SOD1 for both sporadic and familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A (2007) 2.25
Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. J Neurochem (2005) 1.91
Transgenic rat model of neurodegeneration caused by mutation in the TDP gene. PLoS Genet (2010) 1.81
Reactive astrocytes secrete lcn2 to promote neuron death. Proc Natl Acad Sci U S A (2013) 1.59
Factors associated with Type I and Type II endometrial cancer. Cancer Causes Control (2010) 1.52
Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics. Muscle Nerve (2010) 1.48
Functional repression of cAMP response element in 6-hydroxydopamine-treated neuronal cells. J Biol Chem (2006) 1.25
Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: a mitotic catastrophe? Acta Neuropathol (2003) 1.24
YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor. Am J Pathol (2008) 1.23
Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener (2013) 1.16
Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS. J Neurochem (2011) 1.10
Cystatin C: a candidate biomarker for amyotrophic lateral sclerosis. PLoS One (2010) 1.08
Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease. J Neurosci Res (2004) 1.03
Environmental and occupational risk factors for amyotrophic lateral sclerosis: a case-control study. Neurodegener Dis (2013) 1.03
Altered distribution of cell cycle transcriptional regulators during Alzheimer disease. J Neuropathol Exp Neurol (2002) 1.02
SOD1 in cerebral spinal fluid as a pharmacodynamic marker for antisense oligonucleotide therapy. JAMA Neurol (2013) 1.01
Altered subcellular distribution of c-Abl in Alzheimer's disease. J Alzheimers Dis (2009) 0.99
Focal adhesions regulate Abeta signaling and cell death in Alzheimer's disease. Biochim Biophys Acta (2006) 0.98
Fetal Alz-50 clone 1 interacts with the human orthologue of the Kelch-like Ech-associated protein. Biochemistry (2004) 0.96
Hyperphosphorylation of the retinoblastoma gene product and altered subcellular distribution of E2F-1 during Alzheimer's disease and amyotrophic lateral sclerosis. J Alzheimers Dis (2001) 0.96
Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42. Biomark Med (2012) 0.95
The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients. Acta Neuropathol (2012) 0.95
Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS. Amyotroph Lateral Scler (2012) 0.95
Alzheimer disease pathology in amyotrophic lateral sclerosis. Acta Neuropathol (2004) 0.94
Biochemical alterations associated with ALS. Amyotroph Lateral Scler (2011) 0.94
The application of biomarkers in clinical trials for motor neuron disease. Biomark Med (2010) 0.92
Pesticide exposure as a risk factor for amyotrophic lateral sclerosis: a meta-analysis of epidemiological studies: pesticide exposure as a risk factor for ALS. Environ Res (2012) 0.91
pNfH is a promising biomarker for ALS. Amyotroph Lateral Scler Frontotemporal Degener (2012) 0.91
Protein biomarkers for amyotrophic lateral sclerosis. Expert Rev Proteomics (2008) 0.91
Therapeutic neuroprotective agents for amyotrophic lateral sclerosis. Cell Mol Life Sci (2013) 0.88
Comparison of survival outcomes between patients with malignant mixed mullerian tumors and high-grade endometrioid, clear cell, and papillary serous endometrial cancers. Int J Gynecol Cancer (2011) 0.88
Retinoblastoma protein phosphorylation at multiple sites is associated with neurofibrillary pathology in Alzheimer disease. Int J Clin Exp Pathol (2008) 0.87
Increased expression of p130 in Alzheimer disease. Neurochem Res (2006) 0.87
A pilot trial of memantine and riluzole in ALS: correlation to CSF biomarkers. Amyotroph Lateral Scler (2010) 0.86
Survival outcomes in endometrial cancer patients are associated with CXCL12 and estrogen receptor expression. Int J Cancer (2012) 0.84
A Pilot Trial of Pioglitazone HCl and Tretinoin in ALS: Cerebrospinal Fluid Biomarkers to Monitor Drug Efficacy and Predict Rate of Disease Progression. Neurol Res Int (2012) 0.82
Novel Death Defying Domain in Met entraps the active site of caspase-3 and blocks apoptosis in hepatocytes. Hepatology (2014) 0.82
Measurement of cystatin C functional activity in the cerebrospinal fluid of amyotrophic lateral sclerosis and control subjects. Fluids Barriers CNS (2013) 0.82
Paxillin and hydrogen peroxide-inducible clone 5 expression and distribution in control and Alzheimer disease hippocampi. J Neuropathol Exp Neurol (2010) 0.81
DNA damage induces cdk2 protein levels and histone H2B phosphorylation in SH-SY5Y neuroblastoma cells. J Alzheimers Dis (2005) 0.81
Neuroprotection for amyotrophic lateral sclerosis: role of stem cells, growth factors, and gene therapy. Cent Nerv Syst Agents Med Chem (2012) 0.81
p53 and Cell Cycle Proteins Participate in Spinal Motor Neuron Cell Death in ALS. Open Pathol J (2010) 0.80
Von Willebrand factor promoter targets the expression of amyloid beta protein precursor to brain vascular endothelial cells of transgenic mice. J Alzheimers Dis (2003) 0.80
Assessment of Protein Stability in Cerebrospinal Fluid Using Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Protein Profiling. Clin Proteomics (2006) 0.80
Retinoid signaling alterations in amyotrophic lateral sclerosis. Am J Neurodegener Dis (2012) 0.80
Proposed BioRepository platform solution for the ALS research community. Amyotroph Lateral Scler (2010) 0.80
Plasma and cerebrospinal fluid-based protein biomarkers for motor neuron disease. Mol Diagn Ther (2006) 0.79
Altered expression and distribution of FAC1 during NGF-induced neurite outgrowth of PC12 cells. Neuroreport (2003) 0.78
Plasma metabolomic biomarker panel to distinguish patients with amyotrophic lateral sclerosis from disease mimics. Amyotroph Lateral Scler Frontotemporal Degener (2014) 0.78
Chemokines and Cancer Progression: A Qualitative Review on the Role of Stromal Cell-derived Factor 1-alpha and CXCR4 in Endometrial Cancer. Cancer Microenviron (2010) 0.78
Comparative proteomic profiling of cerebrospinal fluid between living and post mortem ALS and control subjects. Amyotroph Lateral Scler (2007) 0.78
Carbonic anhydrase I is recognized by an SOD1 antibody upon biotinylation of human spinal cord extracts. Int J Mol Sci (2010) 0.77
Identification of a complex between fibronectin and aggrecan G3 domain in synovial fluid of patients with painful meniscal pathology. Clin Biochem (2010) 0.77
ALS Untangled No. 20: the Deanna protocol. Amyotroph Lateral Scler Frontotemporal Degener (2013) 0.77
Increased Cyclin G1 Immunoreactivity During Alzheimer's Disease. J Alzheimers Dis (1999) 0.76
Post-lumbar puncture headache is reduced with use of atraumatic needles in ALS. Amyotroph Lateral Scler Frontotemporal Degener (2013) 0.76
Genetic variation in ESR2 and estrogen receptor-beta expression in lung tumors. Cancer Epidemiol (2013) 0.75
PhD graduate training programs in pathology: 2003 report from the American Society for Investigative Pathology workshop on pathology graduate education. Hum Pathol (2004) 0.75
The 12th International Symposium on ALS/MND: scientific advancements in amyotrophic lateral sclerosis. November 18-20, 2001, Oakland, Calif. Brain Pathol (2002) 0.75